🇺🇸 FDA
Pipeline program

Liposomal Ciclosporin A, Liposomal Ciclosporin A

BT–L-CsA–303–FU

Phase 3 small_molecule active

Quick answer

Liposomal Ciclosporin A, Liposomal Ciclosporin A for Bronchiolitis Obliterans Syndrome in Patients post Single or post Double Lung Transplantation is a Phase 3 program (small_molecule) at Zambon SpA with 1 ClinicalTrials.gov record(s).

Program details

Company
Zambon SpA
Indication
Bronchiolitis Obliterans Syndrome in Patients post Single or post Double Lung Transplantation
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials